First new drug in 40 years raises hope for better TB treatment

December 28, 2012--Today, the U.S. Food and Drug Administration (FDA) approved bedaquiline as the first new drug for tuberculosis (TB) in 40 years. This important news comes at a time when the incidence of multi-drug resistant (MDR) TB is growing worldwide and public health officials are in desperate need of better drugs to contain the most dangerous strains.